M&A Deal Summary |
|
---|---|
Date | 2019-12-10 |
Target | R&S Northeas |
Sector | Medical Products |
Buyer(s) | Amneal Pharmaceuticals |
Deal Type | Add-on Acquisition |
Deal Value | 340M USD |
Advisor(s) | Raymond James - Investment Banking (Financial) Frost Brown Todd (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2002 |
Sector | Healthcare Services |
Employees | 7,850 |
Revenue | 2.4B USD (2023) |
Amneal Pharmaceuticals manufactures and supplies generic pharmaceuticals. The company offers prescription pharmaceutical products in various forms, including oral solids that range from tablets to capsules and soft gels; and liquid-form pharmaceuticals that range from suspensions to solutions. Amneal Pharmaceuticals was incorporated in 2002 and is based in Bridgewater, New Jersey.
DEAL STATS | # |
---|---|
Overall | 4 of 6 |
Sector (Medical Products) | 1 of 1 |
Type (Add-on Acquisition) | 3 of 3 |
State (Tennessee) | 1 of 1 |
Country (United States) | 4 of 6 |
Year (2019) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-05-17 |
Amneal Deutschland
Gröbenzell, Germany Amneal Deutschland GmbH is a manufacturer and distributor of pharmaceuticals products. Amneal Deutschland GmbH is based in Gröbenzell, Germany. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-04-05 |
Kashiv Specialty Pharmaceuticals
Piscataway, New Jersey, United States Kashiv Specialty Pharmaceuticals is a developer of complex generics, innovative drug delivery platforms and novel 505(b)(2) drugs. Kashiv Specialty Pharmaceuticals is based in Piscataway, New Jersey. |
Buy | - |